标题
Targeting histone deacetylases in T-cell lymphoma
作者
关键词
-
出版物
LEUKEMIA & LYMPHOMA
Volume 58, Issue 6, Pages 1306-1319
出版商
Informa UK Limited
发表日期
2016-11-04
DOI
10.1080/10428194.2016.1247956
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma
- (2016) Barbara Pro et al. HEMATOLOGICAL ONCOLOGY
- Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
- (2016) Francine Foss et al. Journal of Hematology & Oncology
- Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma
- (2015) Y. Shi et al. ANNALS OF ONCOLOGY
- Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data
- (2015) Susan E. Bates et al. BRITISH JOURNAL OF HAEMATOLOGY
- Advanced-Stage Mycosis Fungoides and Sézary Syndrome: Survival and Response to Treatment
- (2015) Silvia Alberti-Violetti et al. Clinical Lymphoma Myeloma & Leukemia
- Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study
- (2015) Owen A. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Romidepsin targets multiple survival signaling pathways in malignant T cells
- (2015) B C Valdez et al. Blood Cancer Journal
- Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study
- (2015) Jehan Dupuis et al. Lancet Haematology
- Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial
- (2014) Georg Hopfinger et al. ANNALS OF HEMATOLOGY
- How I treat the peripheral T-cell lymphomas
- (2014) A. J. Moskowitz et al. BLOOD
- A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma
- (2014) Francine Foss et al. BRITISH JOURNAL OF HAEMATOLOGY
- Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses
- (2014) Bertrand Coiffier et al. Journal of Hematology & Oncology
- A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma
- (2013) Lihua E. Budde et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma
- (2013) Yasuhiro Oki et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase I Study of Panobinostat plus Everolimus in Patients with Relapsed or Refractory Lymphoma
- (2013) Y. Oki et al. CLINICAL CANCER RESEARCH
- Electrocardiographic Studies of Romidepsin Demonstrate Its Safety and Identify a Potential Role for KATP Channel
- (2013) A. M. Noonan et al. CLINICAL CANCER RESEARCH
- Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCENT Database
- (2013) Qian Shi et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sezary Syndrome from 1982 to 2009
- (2012) R. Talpur et al. CLINICAL CANCER RESEARCH
- Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial
- (2012) Madeleine Duvic et al. EUROPEAN JOURNAL OF CANCER
- Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
- (2012) Bertrand Coiffier et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinically meaningful reduction in pruritus in patients with cutaneous T-cell lymphoma treated with romidepsin
- (2012) Youn H. Kim et al. LEUKEMIA & LYMPHOMA
- Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma:in vitroand phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition
- (2012) Reinhard Dummer et al. LEUKEMIA & LYMPHOMA
- HDAC inhibitor-based therapies: Can we interpret the code?
- (2012) Maria New et al. Molecular Oncology
- Peripheral T-cell lymphoma
- (2011) F. M. Foss et al. BLOOD
- Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
- (2011) R. L. Piekarz et al. BLOOD
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma
- (2010) J. Kikuchi et al. BLOOD
- Inhibition of Histone Deacetylase in Cancer Cells Slows Down Replication Forks, Activates Dormant Origins, and Induces DNA Damage
- (2010) Chiara Conti et al. CANCER RESEARCH
- A work in progress: The clinical development of histone deacetylase inhibitor
- (2010) Silvia Marsoni et al. Epigenetics
- Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal
- (2010) Nita Sally Agar et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
- (2010) Sean J. Whittaker et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
- (2010) T E Witzig et al. LEUKEMIA
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- Acquired vorinostat resistance shows partial cross-resistance to ‘second-generation’ HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities
- (2009) Konstantin J. Dedes et al. ANTI-CANCER DRUGS
- Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma
- (2009) Ulrike Heider et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas
- (2009) Lena Marquard et al. HISTOPATHOLOGY
- Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
- (2009) Thomas E. Witzig et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- HDAC family: What are the cancer relevant targets?
- (2008) Olaf Witt et al. CANCER LETTERS
- A Phase 1 Pharmacokinetic and Pharmacodynamic Study of the Histone Deacetylase Inhibitor Belinostat in Patients with Advanced Solid Tumors
- (2008) N. L. Steele et al. CLINICAL CANCER RESEARCH
- Phase I Pharmacokinetic and Pharmacodynamic Study of LAQ824, a Hydroxamate Histone Deacetylase Inhibitor with a Heat Shock Protein-90 Inhibitory Profile, in Patients with Advanced Solid Tumors
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
- (2008) L. Ellis et al. CLINICAL CANCER RESEARCH
- Cutaneous T-cell Lymphoma
- (2008) Frederick Lansigan et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
- (2008) Peter H. Wiernik et al. JOURNAL OF CLINICAL ONCOLOGY
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes
- (2008) JOURNAL OF CLINICAL ONCOLOGY
- Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study
- (2008) Peter Reimer et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search